Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QUOTED. Sept. 11, 2018. Kellyanne Conway.

Executive Summary

Stacy Cline Amin will join US FDA as chief counsel on Sept. 17. Amin comes from the White House, where she served as special assistant and senior associate counsel to President Trump. See what Kellyanne Conway, senior counselor to the president, said about Amin here.

"Stacy is an instrumental part of the Trump administration’s whole of government work to combat drug demand and the opioid crisis, including during the launch of the campaign to stop youth opioid abuse. [US FDA] is fortunate to have a brilliant lawyer and faithful public servant as the administration continues to implement important policies that will lower prescription drug prices, fast-track opioid alternatives for pain management and reduce the use of e-cigarettes among America’s youth." –Kellyanne Conway, senior counselor to President Donald Trump

Click here for a free trial of Medtech Insight

 

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT123235

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel